epigallocatechin gallate has been researched along with Injuries, Spinal Cord in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Hasnawi, SS; Almajidi, YQ; Alsaab, HO; Alshahrani, SH; Hasan, EK; Hassan, ZF; Musad Saleh, EA; Mustafa, YF; Pant, R; Romero-Parra, RM | 1 |
| Amin, A; Dubisova, J; Jendelova, P; Jhanwar-Uniyal, M; Karova, K; Kloudova, A; Kubinova, S; Machova Urdzikova, L; Ruzicka, J; Schmidt, M; Svobodova, B | 1 |
| Khademi, E; Khalatbary, AR | 1 |
| Diao, Y; Ge, R; Tao, L; Xiong, XC; Yuan, W; Zhu, Y | 1 |
| Abul, H; Al-Khaledi, G; Asfar, S; Karam, SM; Mousa, A; Renno, WM | 1 |
| Alberch, J; Boadas-Vaello, P; Puig, T; Turrado, C; Verdú, E; Vidal-Sancho, L; Xifró, X | 1 |
| Álvarez-Pérez, B; Boadas-Vaello, P; Bosch-Mola, M; Homs, J; Puig, T; Reina, F; Verdú, E | 1 |
| Ahmadvand, H; Boroujeni, MB; Khalatbary, AR; Tamjidipoor, A; Tavafi, M; Tiraihi, T | 1 |
| Ahmadvand, H; Khalatbary, AR | 1 |
| Han, XG; Liu, B; Liu, YJ; Tang, GQ; Tian, W; Wang, YQ; Xiao, B; Xu, YF | 1 |
1 review(s) available for epigallocatechin gallate and Injuries, Spinal Cord
| Article | Year |
|---|---|
The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection.
Topics: Animals; Apoptosis; Brain; Brain Injuries; Catechin; Clinical Trials as Topic; Humans; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Plant Extracts; Spinal Cord Injuries; Tea | 2020 |
9 other study(ies) available for epigallocatechin gallate and Injuries, Spinal Cord
| Article | Year |
|---|---|
Hyperbaric Oxygen in Combination with Epigallocatechin-3-Gallate Synergistically Enhance Recovery from Spinal Cord Injury in Rats.
Topics: Animals; Hyperbaric Oxygenation; Male; Oxygen; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries | 2023 |
A green tea polyphenol epigallocatechin-3-gallate enhances neuroregeneration after spinal cord injury by altering levels of inflammatory cytokines.
Topics: Animals; Axons; Behavior, Animal; Catechin; Cytokines; Inflammation Mediators; Male; Myelitis; Nerve Regeneration; Neuroprotective Agents; NF-kappa B; Rats, Wistar; Signal Transduction; Spinal Cord Injuries; Tea | 2017 |
Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats.
Topics: Animals; Aquaporin 4; Blotting, Western; Catechin; Disease Models, Animal; Edema; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 2013 |
(-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats.
Topics: Animals; Behavior, Animal; Catechin; Female; Neurons; Neuroprotective Agents; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries | 2014 |
Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.
Topics: Animals; Catechin; Cell Membrane; Cytokines; Fatty Acid Synthase, Type I; Fatty Acids; Gene Expression Regulation; Hyperalgesia; Male; Mice; Neuralgia; Pain; Pain Threshold; Peripheral Nerve Injuries; Spinal Cord Injuries | 2015 |
Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice.
Topics: Animals; Catechin; Contusions; Down-Regulation; Female; Hyperalgesia; Locomotion; Mice; Mice, Inbred BALB C; Nerve Fibers; Nociceptors; Pain Measurement; Recovery of Function; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Spinal Cord; Spinal Cord Injuries; Tumor Necrosis Factor-alpha | 2016 |
Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Catechin; Dyskinesias; Female; Immunohistochemistry; In Situ Nick-End Labeling; Lipid Peroxidation; Neuroprotective Agents; Neuropsychological Tests; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Time Factors; Treatment Outcome | 2010 |
Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Cyclooxygenase 2; Densitometry; Immunohistochemistry; Interleukin-1beta; Male; Myelin Sheath; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Peroxidase; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Tumor Necrosis Factor-alpha; Tyrosine | 2011 |
Intrathecal epigallocatechin gallate treatment improves functional recovery after spinal cord injury by upregulating the expression of BDNF and GDNF.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; Catechin; Female; Glial Cell Line-Derived Neurotrophic Factor; Motor Activity; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries | 2013 |